EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Re-Engagement of Hepatitis C Patients Lost to Follow-Up: A Multicenter Study from Argentina

Fernando Cairo iD, Nicolás Domínguez iD, Andrea Curia iD, Lucía Navarro iD, Manuel Barbero iD, Ayelen Trillo iD, Daniel Calfunao iD, Rodrigo Belloni iD, Anselmo Adrián Bologna iD, Estefanía Burgos iD, Melina Susana iD, Silvia Mabel Borzi iD und 3 weitere

Acta Gastroenterológica Latinoamericana · 30.06.2026 · 56 (2) · 174-195

DOI: 10.52787/agl.v56i2.604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Gastroenterológica Latinoamericana, online erschienen am 30.06.2026. Verfasst von Fernando Cairo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Hospital El Cruce. Florencio Varela, Provincia de Buenos Aires. Argentina Hospital El Cruce Florencio VarelaProvincia de Buenos Aires Argentina. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and aims. Many anti-HCV-positive individuals in Argentina remain lost to follow-up. We assessed a multicenter re-engagement program using complementary case-finding strategies, described the care cascade, and evaluated treatment outcomes.

Methods

Five public hospitals implemented two strategies: laboratory-based screening at a tertiary hospital and its primary/secondary network, and combined medical record/laboratory searches at four tertiary hospitals to identify prior anti-HCV-positive individuals. Lost to follow-up was operationally defined as no documented hepatology care, HCV RNA testing, or antiviral treatment within participating institutions for ≥ 12 months. A two-visit pathway was offered. Primary outcomes were re-engagement, treatment initiation, and sustained virologic response at 12 weeks (SVR12); secondary outcomes were fibrosis stage and SVR4-SVR12 concordance. As an exploratory objective, all-cause mortality was assessed in the laboratory cohort using conditional logistic regression.

Results

Across 206,053 data sources (106,917 laboratory samples and 99,136 medical records), 3,334 individuals were anti-HCV positive. After excluding patients who had been cured (n = 741), were deceased (n = 419), or had undergone liver transplantation (n = 25), 2,149 were potentially eligible for re-engagement, of whom 422 (19.6%) were successfully re-engaged. Significant fibrosis (≥ F2 by FibroScan®) was present in 311 patients (73.7%). Antiviral therapy was initiated in 224 patients, with sofosbuvir/velpatasvir prescribed in 70.1% and glecaprevir/pibrentasvir in 29.9%. SVR12 was achieved in 97.9% of treated patients. In a subset of 112 patients, SVR4 showed 100% concordance with SVR12. In the laboratory cohort, anti-HCV positivity was independently associated with higher all-cause mortality (OR 4.75; 95% CI 3.82–5.94).

Conclusions

Complementary case-finding strategies combined with a simplified two-visit care pathway enabled effective re-engagement and timely treatment, achieving near-universal virologic cure. This scalable model supports hepatitis C micro-elimination across public hospital networks.

Autor:innen und Institutionen

  • Hospital El Cruce. Florencio Varela, Provincia de Buenos Aires. Argentina Hospital El Cruce Florencio VarelaProvincia de Buenos Aires Argentina.
  • Hospital de Clínicas, José de San Martín. Universidad de Buenos Aires, Ciudad Autónoma de Buenos Aires. Argentina Universidad de Buenos Aires Hospital de Clínicas, José de San Martín Universidad de Buenos Aires Ciudad A…
  • Hospital Interzonal General de Agudos Profesor Dr. Rodolfo Rossi, La Plata, Provincia de Buenos Aires. Argentina Hospital Interzonal General de Agudos Profesor Dr. Rodolfo Rossi La PlataProvincia de Buenos Aires Argenti…
  • Hospital Interzonal General de Agudos General José de San Martín, La Plata, Provincia de Buenos Aires. Argentina Hospital Interzonal General de Agudos General José de San Martín La PlataProvincia de Buenos Aires Argenti…
  • Hospital Provincial Dr. Castro Rendón, Provincia de Neuquén. Argentina Hospital Provincial Dr. Castro Rendón Provincia de Neuquén Argentina.

ORCID-Profile: Fernando Cairo, Nicolás Domínguez, Andrea Curia, Lucía Navarro, Manuel Barbero, Ayelen Trillo, Daniel Calfunao, Rodrigo Belloni, Anselmo Adrián Bologna, Estefanía Burgos, Melina Susana, Silvia Mabel Borzi, Omar Andrés Galdame, Esteban González Ballerga, Ignacio Roca

Zitieren

APA

Cairo, F., Domínguez, N., Curia, A., Navarro, L., Barbero, M., Trillo, A., Calfunao, D., Belloni, R., Bologna, A. A., Burgos, E., Susana, M., Borzi, S. M., Galdame, O. A., Ballerga, E. G., & Roca, I. (2026). Re-Engagement of Hepatitis C Patients Lost to Follow-Up: A Multicenter Study from Argentina. Acta Gastroenterológica Latinoamericana, 56(2), 174-195. https://doi.org/10.52787/agl.v56i2.604

Vancouver

Cairo F, Domínguez N, Curia A, Navarro L, Barbero M, Trillo A, et al. Re-Engagement of Hepatitis C Patients Lost to Follow-Up: A Multicenter Study from Argentina. Acta Gastroenterológica Latinoamericana. 2026;56(2):174-195. doi:10.52787/agl.v56i2.604

BibTeX
@article{Cairo2026,
  author = {Cairo, Fernando and Domínguez, Nicolás and Curia, Andrea and Navarro, Lucía and Barbero, Manuel and Trillo, Ayelen and Calfunao, Daniel and Belloni, Rodrigo and Bologna, Anselmo Adrián and Burgos, Estefanía and Susana, Melina and Borzi, Silvia Mabel and Galdame, Omar Andrés and Ballerga, Esteban González and Roca, Ignacio},
  title = {Re-Engagement of Hepatitis C Patients Lost to Follow-Up: A Multicenter Study from Argentina},
  journal = {Acta Gastroenterológica Latinoamericana},
  year = {2026},
  volume = {56},
  number = {2},
  pages = {174--195},
  doi = {10.52787/agl.v56i2.604}
}
Kostenlos starten →